Clinical Trial

Study to Evaluate the Feasibility of Twice Daily Use of Topical Azelaic Acid in Breast Cancer Patients Undergoing Radiation

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This pilot study will evaluate the feasibility of at least twice daily use of azelaic acid in breast cancer patients undergoing radiation treatment.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-11-30 -> 2027-11-30 2026-07-15
minor Completion pushed: 2026-11-30 -> 2027-11-30 2026-07-15
Trial Details
NCT Number NCT06966388
Lead Sponsor Virginia Commonwealth University
Conditions Breast Cancer
Enrollment 33 participants
Start Date 2025-08-13
Primary Completion 2027-11-30 (estimated)
Study Completion 2027-11-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-14